The ongoing Bundibugyo strain outbreak in the Democratic Republic of the Congo, declared in mid-May 2026, is the dominant driver of trader sentiment on countries reporting Ebola cases this year. This fast-moving epidemic has already generated over 5,000 confirmed cases and 2,300-plus deaths, surpassing prior DRC records and expanding across multiple provinces amid conflict and mobility challenges. Imported cases have surfaced in Uganda, which recently declared itself free after swift containment, and one confirmed instance in France, with limited reports of treatment in Germany. Traders watch closely for further cross-border spread or new detections, as contact tracing gaps and the lack of a ready vaccine for this variant keep uncertainty elevated ahead of year-end resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$33,965 Vol.
30. Dez. 2026
South Sudan
66%
Rwanda
27%
Burundi
31%
United States
24%
Canada
28%
Kenya
49%
India
14%
Republic of the Congo
26%
Nigeria
21%
Ethiopia
49%
Somalia
35%
China
18%
$33,965 Vol.
South Sudan
$2,058 Vol.
66%
Rwanda
$2,128 Vol.
27%
Burundi
$200 Vol.
31%
United States
$10,195 Vol.
24%
Canada
$1,086 Vol.
28%
Kenya
$195 Vol.
49%
India
$732 Vol.
14%
Republic of the Congo
$12,150 Vol.
26%
Nigeria
$25 Vol.
21%
Ethiopia
$65 Vol.
49%
Somalia
$71 Vol.
35%
China
$3,106 Vol.
18%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo strain outbreak in the Democratic Republic of the Congo, declared in mid-May 2026, is the dominant driver of trader sentiment on countries reporting Ebola cases this year. This fast-moving epidemic has already generated over 5,000 confirmed cases and 2,300-plus deaths, surpassing prior DRC records and expanding across multiple provinces amid conflict and mobility challenges. Imported cases have surfaced in Uganda, which recently declared itself free after swift containment, and one confirmed instance in France, with limited reports of treatment in Germany. Traders watch closely for further cross-border spread or new detections, as contact tracing gaps and the lack of a ready vaccine for this variant keep uncertainty elevated ahead of year-end resolution.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Markt eröffnet: May 22, 2026, 12:35 PM ET
Volumen
$33,965Enddatum
31. Dez. 2026Markt eröffnet
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo strain outbreak in the Democratic Republic of the Congo, declared in mid-May 2026, is the dominant driver of trader sentiment on countries reporting Ebola cases this year. This fast-moving epidemic has already generated over 5,000 confirmed cases and 2,300-plus deaths, surpassing prior DRC records and expanding across multiple provinces amid conflict and mobility challenges. Imported cases have surfaced in Uganda, which recently declared itself free after swift containment, and one confirmed instance in France, with limited reports of treatment in Germany. Traders watch closely for further cross-border spread or new detections, as contact tracing gaps and the lack of a ready vaccine for this variant keep uncertainty elevated ahead of year-end resolution.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$33,965Enddatum
31. Dez. 2026Markt eröffnet
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...The ongoing Bundibugyo strain outbreak in the Democratic Republic of the Congo, declared in mid-May 2026, is the dominant driver of trader sentiment on countries reporting Ebola cases this year. This fast-moving epidemic has already generated over 5,000 confirmed cases and 2,300-plus deaths, surpassing prior DRC records and expanding across multiple provinces amid conflict and mobility challenges. Imported cases have surfaced in Uganda, which recently declared itself free after swift containment, and one confirmed instance in France, with limited reports of treatment in Germany. Traders watch closely for further cross-border spread or new detections, as contact tracing gaps and the lack of a ready vaccine for this variant keep uncertainty elevated ahead of year-end resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen